DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹15,937 Cr |
Mar2023 | ₹14,863 Cr |
Mar2022 | ₹14,619 Cr |
Mar2021 | ₹11,387 Cr |
Mar2020 | ₹9,425 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹15,937 Cr | 7.23 | |
Mar2023 | ₹14,863 Cr | 1.67 | |
Mar2022 | ₹14,619 Cr | 28.39 | |
Mar2021 | ₹11,387 Cr | 20.82 | |
Mar2020 | ₹9,425 Cr | - |
Compare Total Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹180,090.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
MANKIND PHARMA | ₹111,429.0 Cr | 11.1% | 13.3% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.2% |
1.7% |
47.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses